SCHEMBL16201375

SCHEMBL16201375

CCCN(C)Cc1c[nH]nc1-c1ccc(F)c(Cl)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 1/20 0.36
PGR P06401 4/20 0.33
PRMT6 Q96LA8 3/20 0.33
PRMT8 Q9NR22 3/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
FYN P06241 1/20 0.32
ICMT O60725 1/20 0.32
ERCC1 P07992 1/20 0.32
ERCC4 Q92889 1/20 0.32
MET P08581 1/20 0.32
AXL P30530 1/20 0.32
MERTK Q12866 1/20 0.32
TSPO P30536 1/20 0.32
NR1H4 Q96RI1 1/20 0.32
PRMT1 Q99873 2/20 0.31
PRMT3 O60678 1/20 0.31
CARM1 Q86X55 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16201378 0.91 PIM1 (0.33) PRMT6PRMT8PRMT1PRMT3CARM1
SCHEMBL16201214 0.91 PRMT6 (0.42) NISCHPRMT6PRMT8ADORA2AADORA1
SCHEMBL16201386 0.87 ALDH1A1 (0.35) PRMT6PRMT8PRMT1MOK
SCHEMBL16201366 0.86 PRMT6 (0.36) PRMT6PRMT8PRMT1PRMT3CARM1
SCHEMBL16201390 0.86 PRMT6 (0.39) PRMT6PRMT8ADORA2AADORA1PRMT1
SCHEMBL16201347 0.85 CRHR1 (0.38) ADORA1TSPOPRMT1CARM1CYP1A2
SCHEMBL16201420 0.85 ALDH1A1 (0.39)
SCHEMBL16125846 0.85 MPL (0.39) PRMT6PRMT8PRMT1PRMT3CARM1
SCHEMBL16125841 0.84 NOTUM (0.41) PRMT6PRMT8PRMT1PRMT3CARM1
SCHEMBL16201373 0.83 STK4 (0.44) PRMT6PRMT8PRMT1CARM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9776972-B2 Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof EPIZYME INC. (US) 2017-10-03 US disclosed
US-9346761-B2 Arginine methyltransferase inhibitors and uses thereof Epizyme, Inc. (US) 2016-05-24 US disclosed
US-20160137609-A1 PYRAZOLE DERIVATIVES AS ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2016-05-19 US disclosed
US-20140323537-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140323537-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 NISCH 3918/4885PGR 4455/4885PRMT6 4/4885
US-20160137609-A1 PYRAZOLE DERIVATIVES AS ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 NISCH 3839/4885PGR 4025/4885PRMT6 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.